Global Chromatography Resin Market Set to Reach USD 2.3 Billion by 2034 with a CAGR of 5.4%

Global Chromatography Resin Industry
Chromatography Resin Market

The global chromatography resin market is projected to grow steadily over the next decade, according to the latest report by Future Market Insights. Estimated at USD 1.4 billion in 2024, the market is expected to reach approximately USD 2.3 billion by 2034, advancing at a CAGR of 5.4% throughout the forecast period.

Chromatography resins play a vital role in various industries, including pharmaceuticals, biotechnology, food and beverages, and environmental testing, as they enable the separation and purification of complex mixtures. With increasing applications across these sectors, the chromatography resin market is set to experience consistent growth.

Market Trends and Highlights

  • Surging adoption of chromatography techniques in food and beverage industry is a factor that will pave the way for market during the forecast period.
  • Continually increasing demand in pharmaceutical and biotechnology industries across the globe, is pacing up the market prospects.
  • Technological advancements in chromatography resins, is among the factors that is advancing swiftly towards market expansion.
  • Expanding applications in environmental testing, is also gaining momentum to propel the market.

Key Takeaways from the Report:

  1. Rising Demand in Biopharmaceuticals
    The biopharmaceutical sector is the primary driver of the chromatography resin market, as resins are crucial for drug discovery, development, and manufacturing. This trend is expected to continue with the increasing focus on biologics and biosimilars.
  2. Growth in Environmental Testing
    Heightened awareness regarding environmental safety is boosting demand for chromatography resins in water and soil testing. This segment is expected to witness significant growth as regulatory standards become more stringent worldwide.
  3. North America Leads the Market
    North America currently dominates the chromatography resin market, owing to its advanced research facilities and high demand in pharmaceutical and biopharmaceutical industries. Asia-Pacific, however, is projected to witness faster growth due to expanding pharmaceutical manufacturing capabilities and increased research and development activities.
  4. Advancements in Resin Technology
    Technological advancements in chromatography resins are enabling more efficient separation processes, which improve the quality and yield of biopharmaceuticals and other products. Innovations in resin composition and performance are expected to support market growth.

Competitive Landscape

The chromatography resin market is characterized by intense competition among key players striving to maintain or enhance their market share through strategic initiatives, product innovation, and differentiation strategies.

Company Portfolio

  • Agilent Technologies is a global leader in life sciences, diagnostics, and applied chemical markets, providing solutions for analytical instrumentation and laboratory workflow optimization. The company offers a range of chromatography resins for analytical and preparative chromatography applications.
  • Their portfolio includes ion exchange resins, affinity chromatography resins, and size exclusion chromatography resins designed for protein purification, nucleic acid separation, and sample analysis.
  • Bio-Rad Laboratories is a multinational manufacturer and distributor of life science research and clinical diagnostic products. The company provides chromatography resins for protein purification, affinity chromatography, and ion exchange chromatography applications.
  • Their chromatography resin portfolio includes pre packed columns, resins for chromatography system integration, and specialty resins for research and bioprocessing.

Key Companies Profiled

  • Agilent Technologies
  • Bio-Rad Laboratories
  • GE Healthcare
  • Waters Corporation
  • Expedeon Ltd
  • Thermo Fisher Scientific Inc.
  • Pall Corporation
  • Merck KGaA
  • Perkin Elmer Inc.
  • Kaneka Corporation
  • Shimadzu Corporation
  • Knauer GmbH
  • Tosoh Bioscience
  • Avantor Performance Materials Inc.
  • Mitsubishi Chemical Corporation
  • W.R. Grace & Co.
  • JSR Micro Inc.
  • Life Technology Corporation

Get the Comprehensive Full Report Now

Segmentation Analysis of the Chromatography Resin Market

By Product Type:

  • Native
  • Synthetic

By Technology Type:

  • Affinity Chromatography
  • Anion Exchange Chromatography
  • Cation Exchange Chromatography
  • Size Exclusion
  • Hydrophobic Interaction

By End User Type:

  • Biopharmaceutical Companies
  • Clinical Research Organizations
  • Academic Institutes

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Optical Coherence Tomography Market to Exceed USD 3,250.70 Million by 2033, Growing at a 9.5% CAGR

Global Optical Coherence Tomography Industry
Global Optical Coherence Tomography Market

The global optical coherence tomography (OCT) market is poised for impressive growth over the next decade. Valued at USD 1,311.70 million in 2023, the market is projected to expand at a robust CAGR of 9.5%, reaching approximately USD 3,250.70 million by 2033.

Optical coherence tomography, a non-invasive imaging technique primarily used in ophthalmology, is witnessing rising demand due to its high-resolution imaging capabilities for diagnosing eye diseases and conditions. Increasing cases of retinal disorders and other age-related eye conditions are key drivers for OCT’s growing adoption. Beyond ophthalmology, advancements are extending OCT applications into cardiology, dermatology, and oncology, broadening its market reach.

Primary Catalysts for the Optical Coherence Tomography Device Market

  • The increasing prevalence of eye conditions such as diabetic retinopathy, glaucoma, and age-related macular degeneration is pushing the demand for optical coherence tomography and early detection in the field of ophthalmology.
  • OCT is finding new uses in disciplines including gastroenterology, dermatology, and cardiology due to ongoing research and development efforts, contributing to market expansion.
  • OCT is a desirable alternative for individuals and healthcare providers because it is less expensive than invasive diagnostic techniques, boosting optical coherence tomography market trends.
  • The OCT market opportunities have increased due to the chances for its application in remote healthcare settings brought about by the expansion of telemedicine and remote monitoring systems.
  • Healthcare organizations and providers are increasingly likely to invest in cutting-edge OCT equipment as global healthcare spending rises to maintain competitiveness and deliver better patient care.

Notable Optical Coherence Tomography Manufacturers

  • Leica Microsystems (Danaher Corporation)
  • Carl Zeiss Meditec AG, Optovue Inc.
  • Topcon Corporation
  • Optopol Technology SP. ZOO
  • Santec Corporation
  • Heidelberg Engineering GmbH
  • Michelson Diagnostics Ltd.
  • Tomophase Inc.
  • Moptim Imaging Technique
  • NIDEK Co. Ltd.
  • Sonostar Technologies Co. Limited
  • Canon Medical Systems, USA
  • Abbott, ZD Medical Inc.
  • CONAVI MEDICAL
  • Excelitas Technologies Corp
  • Novacam Technologies Inc.

Access the Full Report

Key Segments

By Product:

  • Time Domain Optical Coherence Tomography (TD-OCT) Systems
  • Fourier Domain Optical Coherence Tomography (FDOCT) Systems
    • Spectral Domain-OCT
    • Swept Source-OCT

By Application:

  • Clinical
    • Ophthalmology
    • Cardiovascular
    • Dermatology
    • Dental
  • Industrial
    • Non-destructive Testing
    • Industrial Quality Control
    • Others

By Scanning Speed:

  • 400 A-scans/sec
  • 4000 A-scans/sec
  • 20000 A-scans/sec
  • 32000 A-scans/sec
  • 40000 A-scans/sec
  • 70000 A-scans/sec
  • 80000 A-scans/sec
  • 100000 A-scans/sec
  • 250,000 A-scans/sec

By End User:

  • Healthcare Settings
    • Hospitals
    • Ambulatory Surgical Centres
    • Specialty Clinics
  • Food Industry
  • Semiconductor Industries
  • Chemical and Polymer Industries
  • Automotive Industry

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Companion Animal Specialty Drugs Market to Reach USD 56,828.56 Million by 2032 with a CAGR of 4.21%

Companion Animal Specialty Drugs market
Companion Animal Specialty Drugs market

The global companion animal specialty drugs market is on track for steady growth, projected to expand at a CAGR of 4.21% from 2022 to 2032. Currently valued at USD 37,624.67 million in 2022, the market is expected to reach approximately USD 56,828.56 million by the end of the forecast period. This market, which saw a historical CAGR of 5.42% in recent years, reflects a growing commitment to pet health and the increasing demand for advanced treatments.

Rising pet ownership worldwide and a growing awareness of animal health are major factors driving demand for specialty drugs tailored to companion animals. Innovations in veterinary pharmaceuticals, combined with an increasing focus on preventative and therapeutic care for pets, are boosting market expansion. Furthermore, advances in drug formulations and delivery methods are making treatments more effective and accessible for pet owners, enhancing overall animal care.

A Contrast with the Historical Market Scenario

The global market for companion animal specialty drugs generated huge demand in previous years. The forum registered a gradual CAGR of 5.42% during the period from 2017 to 2021. A number of factors are responsible for this substantial growth.

The expert analysts at FMI have analyzed that the development and approval of new drugs for the treatment of animal diseases are spurring the demand for companion animal specialty drugs. It is identified while studying the market in-details that the rising prevalence of obesity amongst pet dogs and other companion animals has resulted in higher sales of anti-obesity drugs.

Furthermore, significant growth in the number of animal healthcare and NGOs in recent years is also a key aspect majorly contributing to the acceleration of the companion animal specialty drugs. Moreover, some pet diseases also cause serious effects on humans and need to be mitigated for the prevention of infection, which is further identified to boost the market size of companion animal specialty drugs.

Strong Industry Players Revolutionize & Upscale the Market-o-comics

The global companion animal specialty drugs market is growing rapidly due to the presence of prominent key players as well as start-ups. Most companies are implementing new strategies for the development of innovative companion animal specialty drugs that cause fewer side effects. Consequently, these factors are anticipated to drive the global companion animal drugs market.

Leaders are focusing on new product launches and adopting inorganic growth strategies to remain competitive and sustain in the market. Partnerships with other players are enhancing product offerings, thus helping the companies to increase their customer base by providing superior quality products.

Recent Developments

  • In February 2021, Vetoquinol acquired Canadian rights for the Profender product family from Elanco Animal Health. The acquisition is poised to impact the company’s revenue and offer business development opportunities in untapped economies.
  • In August 2020, Elanco Animal Health Incorporated announced that it has acquired Bayer Animal Health. The transaction was valued at USD 6.89 billion. This development helped the company to expand itself in the durable animal health industry.
  • In January 2021, Merck Animal Health, known as MSD Animal Health outside the US and Canada, a division of Merck & Co. Inc., announced the collaboration with the Street Dog Coalition to offer medications, vaccines, and treatment for pets of those experiencing homelessness.
  • In June 2021, ALR Technologies SG Pvt. Ltd., the diabetes management company announced the establishment of its new business division which will be the world’s first and only CGM for diabetic companion animals, known as ‘ALRT Animal Health Division.
  • In 2017, Zoetis emerged as a leading player with the highest share of compassion animal specialty drugs, as the company has a considerable and significant market presence, a diverse portfolio of product offerings, and an acute strategic perspective which includes M&As, such as the acquisition of Abaxis in 2018.

Some of the key companies proliferating in the market are:

  • Merck Animal Health (Merck & Co., Inc.)
  • Boehringer Ingelheim International GmbH.
  • Elanco Animal Health Incorporated
  • Virbac S.A.
  • Biogenesis Bago SA
  • Piramal Group
  • Zoetis
  • NEOGEN Corporation.
  • Vetoquinol S.A.
  • Ceva Santé Animale

Get Complete Full Report

Key Segments in the Companion Animal Specialty Drugs Market

By Product:

  • Antibiotics
  • Anti-Inflammatory Drugs
  • Parasiticides
  • Heartworm
  • Behavioral Products
  • Nutritional Products
  • Anti-Obesity Drugs
  • Skin Care Products
  • Vaccines

By Distribution Channel:

  • Modern Trade
  • Online Distribution
  • Neighborhood Stores
  • Other Retail Format

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Middle East & Africa (MEA)
  • Europe

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Nerve Repair Market Set to Achieve USD 861.4 Million by 2033, Growing at 12.2% CAGR

Global Nerve Repair Industry
Global Nerve Repair Market

The global nerve repair market is projected for robust growth, with total sales expected to exceed USD 272.4 million in 2023. Driven by the rising prevalence of neurological conditions and advancements in nerve repair therapies, the market is anticipated to expand at a CAGR of 12.2% from 2023 to 2033, reaching an estimated USD 861.4 million by the end of the forecast period.

The increasing incidence of nerve injuries and neurological disorders, coupled with a growing aging population, is fueling demand for effective nerve repair solutions. Innovations in surgical techniques and biomaterials are enhancing the efficacy of nerve repair treatments, boosting adoption rates among healthcare providers and improving patient outcomes. Additionally, advancements in regenerative medicine and stem cell therapies are creating new opportunities for nerve repair, providing hope for patients with nerve damage that previously had limited treatment options.

North America currently dominates the global nerve repair market, supported by a well-established healthcare system and high awareness among medical professionals. Meanwhile, Asia-Pacific is expected to witness significant growth in the coming years, driven by expanding healthcare access and increasing investments in medical infrastructure.

For instance, in 2022, Medtronic announced the approval for its Intellis neurostimulator and the Vanta neurostimulator from the United States Food and Drug Administration (FDA) for the chronic pain treatment associated with diabetic peripheral neuropathy (DPN).

When a nerve is damaged, it can lead to serious motor and sensory issues that ache and cause the appendages to malfunction. Hence, health professionals are employing biomaterials in the nerve repair process and are included in products for nerve repair. Autograft is the gold standard for nerve repair procedures, although the specifics of the procedure are determined by the type and severity of the nerve injury.

Advanced nerve repair therapies are used to treat nerve damage brought on by trauma and other factors, which is a key driver influencing the market. Adult stem cells, which can be obtained from adipose tissue, skin, and bone marrow, are now being employed in many developed nations to repair and regenerate nerves.

Competitive Landscape

With several established nerve repair production companies across the globe, the overall market is estimated to be highly fragmented. To maintain a strong foothold in the industry, key players are increasing Research and Development efforts to expand their novel product portfolios. Several products are in their pipeline stage, and the companies are moving their efforts into promoting the regularization and licensing of these pipelined products after assessing their efficacy.

For instance:

  • In May 2023, a new compound was discovered by the United Kingdom Research and Innovation during their research. This compound exhibits the ability to promote nerve regeneration following injuries and safeguard cardiac tissue against the type of harm observed in heart attacks.
  • In October 2022, Phageneis obtained de novo approval from the United States FDA for their Phagenyx neurostimulation system. This innovative system utilizes pharyngeal electrical stimulation to restore the ability to swallow in individuals suffering from severe dysphagia following a stroke.
  • In August 2022, Abbott received United States FDA approval for the ProClaim plus spinal cord stimulation system. The ProClaim Plus system features FlexBurst therapy developed by Abbott. This system is the next generation of Abbott’s BurstDR stimulation technology. It provides FlexBurst 360 therapy. FlexBurst 360 therapy effectively alleviates pain. The therapy targets six specific regions of the torso and extremities.
  • Integra LifeSciences Holding Corporation announced the launch of NeuraGen® 3D Nerve Guide Matrix, a resorbable implant for the repair of peripheral nerve discontinuities, in March 2022.
  • Topline findings from Avance Nerve Graft vs. compared with Conduits in Digital Nerve Injuries from the RECON Clinical Study were released by Axogen, Inc. in May 2022. The company will submit a biologics license application (BLA) in the second half of 2023 with the help of the data collected from this clinical study.
  • Checkpoint Surgical, Inc. introduced The NeuroShield® Chitosan Nerve Wrap in August 2021, expanding its portfolio of intraoperative nerve care products.

Key Market Players

  • Axogen Inc.
  • Stryker Corporation
  • Baxter International Inc.
  • Integra Lifesciences Holdings Corp
  • Neurotex Ltd
  • Polyganics B.V.
  • Abbott Laboratories
  • Boston Scientific Inc
  • Medtronic Plc
  • Checkpoint Surgical
  • Polyganics
  • Synovis Micro Companies Alliance
  • Orthomed, Inc

A Full Report Overview

Key Market Segments Covered in Nerve Repair Industry Research

By Product:

  • Nerve Wrap
  • Nerve Protector
  • Nerve Connector
  • Nerve Graft

By Nerve Repair:

  • Epineural Nerve Repair
  • Perineural Nerve Repair
  • Fascicular Nerve Repair

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Intra-Abdominal Pressure Measurement Devices Market to Reach USD 318.3 Million by 2033 with a Strong CAGR of 12.4%

Intra-Abdominal Pressure Measurement Devices Market
Intra-Abdominal Pressure Measurement Devices Market

The global intra-abdominal pressure measurement devices market is poised for remarkable growth over the next decade, driven by the increasing demand for advanced monitoring solutions in critical care settings. Valued at USD 98.9 million in 2023, the market is projected to expand at a CAGR of 12.4%, reaching an impressive USD 318.3 million by 2033.

The rising prevalence of abdominal compartment syndrome (ACS) and other critical conditions that require intra-abdominal pressure (IAP) monitoring is a significant factor propelling market growth. Intra-abdominal pressure measurement devices play a crucial role in intensive care units (ICUs), providing critical data to manage patients effectively and prevent complications related to elevated IAP. Growing awareness among healthcare providers about the importance of early diagnosis and monitoring of abdominal hypertension is further contributing to the adoption of these devices.

North America currently leads the market, attributed to its advanced healthcare infrastructure and higher awareness among healthcare professionals, while regions such as Asia-Pacific are expected to see accelerated growth due to increased healthcare investments and improved access to critical care.

What are the Factors Restraining Growth in the Intra-abdominal Pressure Measurement Devices Market?

The high risk of complications associated with intra-abdominal pressure measuring procedures is a key factor restraining the market’s growth.

The bladder is often used to monitor intra-abdominal pressure in patients. Bladder infections and needle stick wounds are two significant issues with pressure management devices that could put patients at risk and cause discomfort.

Complicated surgical procedures may result in an elevation of the locations, and adhesion may produce false results regarding the patient’s conditions, hindering the market growth for intra-abdominal pressure measurement devices. There are issues regarding the infusion volume, indications, measurement frequency, and zero-reference point while monitoring the patient. Such conditions are anticipated to impede market expansion.

Competitive Landscape

The market is highly fragmented, with several competitors in the intra-abdominal pressure measurement devices space. These companies are implementing mergers and acquisitions, partnerships and collaborations, and new product launches to meet consumer demand and expand their customer base.

Other Prominent Players in the Global Market are:

  • C.R. Bard, Inc.
  • ConvaTec Group PLC
  • Stryker Corporation
  • Biometrix Ltd. (Degania Silicone, Ltd.)
  • Centurion Medical Products
  • Holtech Medical
  • ConvaTec Group PLC
  • Potrero Medical
  • Gaeltec Devises Ltd.
  • Speigelberg GmbH & Co. KG.
  • C2Dx Inc.
  • Scranton Gillette Communication
  • Nutrimedics S.A.
  • SEM Mthembu Medical (Pty) Ltd
  • Carl Zeiss AG

Instances of key developmental strategies by the industry players in the global market are given below:

  • The United States FDA granted Potrero Medical Inc.’s AKI Predict machine learning algorithm breakthrough device designation in September 2022 for the advanced prediction of acute kidney injury (AKI) linked with intra-abdominal hypertension (IAH) in intensive care patients recovering from heart surgery.
  • On 18 June 2019, C2Dx Inc. acquired the Intra-Compartmental Pressure Monitoring System product line from Stryker Corporation. It is also known as the STIC Monitor and is regarded as an effective method for identifying and treating both acute and chronic compartment syndrome.

Key Companies Profiled

C.R. Bard, Inc.; ConvaTec Group PLC; Stryker Corporation; Biometrix Ltd. (Degania Silicone, Ltd.); Centurion Medical Products; Holtech Medical; ConvaTec Group PLC; Potrero Medical; Gaeltec Devises Ltd.; Speigelberg GmbH & Co. KG.; C2Dx Inc.; Scranton Gillette Communication; Nutrimedics S.A.; SEM Mthembu Medical (Pty) Ltd; Carl Zeiss AG

Full Report Revealed

Market by Category

By Product:

  • Disposables
  • Equipment

By Application:

  • Intra-abdominal Hypertension
  • Intra-compartment Pressure

By End User:

  • Hospitals
  • Clinics
  • Trauma Centers
  • Ambulatory Surgical Centers (ASCs)

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Extended Reality Market Forecast: Reaching USD 755.8 Bn by 2033

The global Extended Reality (XR) Market, encompassing augmented reality (AR), virtual reality (VR), and mixed reality (MR), is projected to see an exponential rise from an estimated USD 47.5 billion in 2023 to a remarkable USD 755.8 billion by 2033, growing at a robust compound annual growth rate (CAGR) of 31.9% over the forecast period. The United States, a major contributor to XR advancements, is expected to witness a CAGR of 31.8% in the same period, underscoring the region’s commitment to leveraging immersive technologies across multiple sectors. With the integration of XR technologies continuing to gain momentum, industries are experiencing transformative impacts, driving demand and fueling rapid market expansion.

Key Takeaways from Market Study:

  • The global Extended Reality Market is projected to grow at a CAGR of 31.9% from 2023 to 2033.
  • The market size is expected to escalate from USD 47.5 billion in 2023 to USD 755.8 billion by 2033.
  • The United States market is set to expand at a 31.8% CAGR over the forecast period, driven by advancements in the healthcare, gaming, and retail sectors.
  • Major contributors to market growth include evolving customer expectations for immersive experiences, rising demand in virtual learning and simulation, and increased applications in industrial settings.

Picture background

Drivers and Opportunities:

The Extended Reality Market is driven by increasing investments in immersive technologies by enterprises seeking to enhance customer engagement and workforce productivity. The rising adoption of AR and VR across industries like healthcare, education, gaming, and retail is pivotal, as companies look to deliver more personalized, impactful experiences. Additionally, technological advancements in hardware and software, coupled with affordable XR devices, are reducing barriers to adoption, creating significant growth opportunities across emerging markets. As XR applications expand, innovations in haptic feedback, multisensory XR systems, and 5G-enabled XR solutions further accelerate market demand, providing a promising landscape for developers and hardware manufacturers alike.

Component Insights:

The XR market’s components span hardware, software, and services, each playing a critical role in the ecosystem. Hardware is expected to dominate, driven by high demand for XR-enabled devices such as headsets, sensors, and smart glasses. Meanwhile, software and services are experiencing rapid growth, as companies focus on developing robust applications and immersive content, enhancing user engagement. Service providers are also capitalizing on growing interest in XR by offering managed and consulting services to help companies implement and maintain XR solutions effectively.

Application Insights:

Extended reality applications are proving invaluable across multiple domains. Healthcare and education sectors are emerging as key beneficiaries, with XR applications supporting advanced medical training, remote patient care, and enhanced learning experiences. The gaming industry remains a pivotal area for XR, consistently driving demand for more immersive experiences. Furthermore, industrial applications are gaining traction, with XR solutions aiding in workforce training, predictive maintenance, and improved operational efficiency. Each sector’s unique use cases highlight XR’s adaptability and potential for long-term impact.

Deployment Insights:

XR solutions can be deployed via cloud-based and on-premise infrastructures, with cloud deployment expected to witness stronger growth due to increased scalability, cost-effectiveness, and accessibility. Cloud deployment also supports collaborative XR experiences and remote access, vital for applications in training and education. On-premise deployment remains relevant for sectors with stringent data security requirements, including healthcare and defense, ensuring flexibility across diverse industry needs.

Key Companies & Market Share Insights:

The Extended Reality Market is highly competitive, with companies like Microsoft Corporation, Meta Platforms, Inc., Alphabet Inc., Sony Corporation, and HTC Corporation at the forefront. These companies continually invest in research and development to introduce innovative XR solutions, maintain market share, and strengthen their global presence. Partnerships, mergers, and acquisitions are also common strategies among key players to expand their product offerings and geographic reach, positioning them to capitalize on growing XR demand.

Recent Developments:

  1. Meta Platforms, Inc. launched a new generation of AR/VR headsets, featuring advanced tracking and haptic feedback, enhancing user immersion.
  2. Microsoft Corporation expanded its XR capabilities through strategic partnerships aimed at enhancing its HoloLens offerings for the industrial sector.
  3. Sony Corporation invested in XR gaming content, leveraging its PlayStation brand to attract gamers to its VR platform.
  4. Alphabet Inc. made significant advancements in XR-powered AI tools, enabling new applications in education and virtual collaboration.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Respiratory Devices Market Poised for Strong Growth, Expected to Reach USD 69,072.5 Million by 2024 with a CAGR of 9.9% through 2034

Global Respiratory Devices Industry
Global Respiratory Devices Market

The global respiratory devices market is on a robust growth trajectory, fueled by advancements in combination therapies for managing chronic respiratory conditions like COPD and asthma. In 2024, the market is expected to reach USD 26,873.7 million, with forecasts projecting an impressive CAGR of 9.9% through 2034, ultimately reaching a valuation of USD 69,072.5 million.

The recent COVID-19 pandemic underscored the importance of respiratory devices in managing respiratory illnesses, spurring healthcare systems and professionals to prioritize these tools for mitigating disease spread and severity. As a result, respiratory devices have become central to respiratory healthcare, enhancing treatment protocols across both developed and developing regions. Medicare advancements, backed by substantial investments from public and private healthcare companies, are further boosting the adoption of these devices, particularly in emerging markets where accessibility is improving rapidly.

Manufacturers are responding by developing affordable, high-quality devices designed to meet the needs of a wider demographic, ensuring broader market access. The growth is also supported by government-led medical inclusion initiatives in underdeveloped and developing nations, which are expanding healthcare access and bringing a larger population under the respiratory device market.

Competitive Landscape

The market, globally, is a well-established one with a multitude of companies vying for international dominance. Hospitals, ambulatory surgical centers, clinics, etc., heavily rely on these companies for their respiratory requirements. These companies are also pouring billions of dollars into the development of product offerings that are not only effective but also affordable for the general populace.

Recent Developments

  • In February 2024, ResMed launched its AirCurve 11 series, featuring bilevel-positive airway pressure devices in the USA The devices utilized inspiratory and expiratory positive airway pressure, aiding sleep apnea treatment with improved comfort and compliance.
  • In August 2023, researchers from the University of Canterbury developed BOB, a tool unlocking respiratory data from devices. It facilitated data-driven respiratory care, reducing costs and wait times for patients. The software, developed by UC Engineering PhD students, provided real-time data interpretation and report generation for GPs.
  • In February 2024, Dräger was honored with Frost & Sullivan’s Company of the Year Award in global respiratory care, recognizing its innovative solutions and customer impact. The award highlighted Dräger’s commitment to excellence in medical technologies and services.
  • In February 2024, University Medical Devices secured US$ 1.6 million in seed funding to launch MicroWash, a groundbreaking nasal specimen collection device. The investment aimed to advance infrastructure and bring the device to market, addressing respiratory infections with a more comfortable alternative to nasal swabs.
  • In April 2024, Clario announced its acquisition of AI-powered software company ArtiQ, bolstering its Respiratory Solutions portfolio. The integration of ArtiQ’s technology with Clario’s devices enhanced data quality and patient experience in respiratory clinical trials.
  • In June 2023, SunMed acquired Avanos Medical’s respiratory health business for US$ 110 million. The deal included inventory, assets, and leases for manufacturing facilities in Mexico. This expanded SunMed’s portfolio after purchasing Vyaire Medical’s hardware earlier that year.
  • In July 2023, ResMed acquired Somnoware, a software maker specializing in sleep and respiratory diagnostics. This strategic move bolstered ResMed’s position in the market, particularly amidst competitor challenges.
  • In October 2022, Australia-based firm AirPhysio launched respiratory devices in Chennai, India. Brett Lee, former Australian cricketer, unveiled the AirPhysio and Better Breathing product range alongside Apollo Hospital’s managing director Suneeta Reddy. The company partnered with Medsmart and Apollo Group for the rollout.

Key Companies

  • Massimo Corporation
  • Teleflex Incorporated
  • Fisher & Paykel Healthcare Limited
  • ResMed Inc.
  • Hamilton Medical AG
  • Medtronic plc.
  • Koninklijke Philips N.V.
  • Smith’s Medical
  • General Electric Healthcare Limited
  • Drägerwerk AG & Co. KGaA
  • Inogen Inc.

A Full Report Analysis

Key Segments of the Respiratory Device Industry

Product Categories:

  • Respiratory Consumables
    • Respiratory Masks
    • Nasal Cannulas
    • Oxygen Tubing Sets
    • Breathing Filters
  • Nebulizers
    • Compressed Jet Nebulizers
    • Ultrasonic Nebulizers
  • Oxygen Concentrators
    • Home Oxygen Concentrators
    • Portable Oxygen Concentrators
    • Positive Airway Pressure (PAP) Devices
    • Polysomnography Devices
    • Ambulatory PSG Devices
    • Clinical PSG Devices
    • Pulse Oximeters
    • Mechanical Ventilators
    • Spirometers

End Users:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Long Term Care Centers
  • Others

Regions:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Obesity Management Market to Reach USD 3,494.5 Million by 2033, Growing at a CAGR of 5.2%

Global Obesity Management Market
Global Obesity Management Market

The global obesity management market is set for steady growth over the next decade, with a projected compound annual growth rate (CAGR) of 5.2% from 2023 to 2033. Valued at approximately USD 2,095.6 million in 2023, the market is anticipated to reach USD 3,494.5 million by 2033, according to recent industry analysis.

This growth is largely driven by increasing obesity rates worldwide, along with rising awareness and demand for effective weight management solutions. The market includes a diverse array of products and services, including pharmacological treatments, lifestyle intervention programs, and surgical solutions. Technological advancements in non-invasive procedures and digital health tools, such as mobile applications and wearables, are further contributing to the expansion of the obesity management market.

The increasing prevalence of obesity-related health conditions, including diabetes, cardiovascular disease, and hypertension, underscores the need for effective management solutions, which is creating a positive growth environment. North America currently leads the global market, while regions such as Asia-Pacific are expected to experience accelerated growth due to rising health awareness and government initiatives addressing obesity.

Due to the steep rise in obesity prevalence over the last two decades, the global market is expected to generate significant revenue in the future. The key factors expected to drive the market are:

  • An increase in the obese population
  • An increase in the number of bariatric surgeries
  • An increase in the adoption of online weight loss and weight management programs
  • An increase in disposable income in developing economies
  • Sedentary lifestyle
  • Increased government initiatives to raise awareness among the obese population

Key Players Profiled in the Global Market

  • GlaxoSmithKline Plc.
  • VIVUS, Inc.
  • Novo Nordisk A/S
  • Currax Pharmaceuticals LLC
  • Cheplapharm Arzneimittel GmbH
  • Bausch Health Companies Inc.
  • Takeda Pharmaceuticals, Inc.

A Detailed Full Report

Key Segmentation

By Drug Type:

  • Bupropion and Naltrexone
  • Orlistat
  • Lorcaserin
  • Phentermine and Topiramate
  • Liraglutide

By Surgery Type:

  • Gastric Bypass Surgery
  • Adjustable Gastric Banding Surgery
  • Gastric Sleeve Surgery
  • Duodenal Switch Surgery
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • E-commerce

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East & Africa (MEA)
  • Europe

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Deception Technology Market 2023 Future Analysis, Demand by Regions and Opportunities with Challenges 2033

The market for deception technology is estimated to reach $2 billion in value by 2023. It is expected to grow to US$ 6.7 billion by 2033, reflecting a 12.6% CAGR between 2023 and 2033. During the same time span, the market might have a US$ 4.7 billion absolute dollar potential.

Because cyber threats are continuously growing, security techniques must evolve as well. Antivirus software and firewalls, which were formerly sufficient for security, are no longer effective against today’s sophisticated attacks.

By setting up a network of deceptive traps and decoys that detect and divert intruders, deception technology provides a proactive security mechanism. This novel strategy is expected to add an extra degree of protection for enterprises. As a result, it would be a desirable approach to counter new cyber threats.

Request a Sample of this Report

Ability of an organization to identify and react is improved by deception technology. Organizations can divert attackers away from vital assets by using realistic decoys. Additionally, they can learn crucial information about their strategies, methods, and objectives.

Early detection enables quick response and correction, reducing the potential harm brought on by cyberattacks. Ability to proactively identify risks and take appropriate action is a key factor driving demand for deception technologies.

Organizations might also be at danger from insider threats. Hence, it is essential to put precautions in place to lessen this risk. By constructing decoys and traps that are only visible to insiders, deception technology can be important in combating insider threats.

The strategy enables businesses to spot dishonest insiders or compromised accounts and take the necessary countermeasures. Deception technology will offer enterprises improved security and peace of mind by giving them a proactive way to identify and stop internal threats.

Demand for deception technologies would also be significantly influenced by compliance and regulatory needs. Strict data protection and security laws apply to a number of sectors, including healthcare, finance, and government.

Deception technology offers an advanced security solution that goes beyond fundamental compliance measures, assisting enterprises in meeting these criteria. Organizations might be sure they are adhering to legal requirements and avoiding penalties by exhibiting proactive security measures.

Corporations might also find deception technology to be a cost-effective security measure. Without making substantial investments in extra hardware, businesses can increase security by strategically installing decoys and traps. This makes the cost of developing deception technologies a viable investment.

Due to the sensitivity or importance of their intellectual property, certain sectors such as defense, critical infrastructure, and high-tech manufacturing, have specific security requirements. Deception technology provides specialized answers to handle these particular challenges. Hence, it might offer specialized decoys and traps that correspond with threats and attack vectors that are unique to a given sector.

Key Takeaways from Deception Technology Market Study:

  • China deception technology industry is projected to witness a CAGR of 5% from 2023 to 2033.
  • The United States deception technology industry witnessed a CAGR of 1% in the historical period.
  • The United Kingdom deception technology industry is anticipated to surpass a valuation of US$ 264 million by 2033.
  • By offering, the solution segment showcased a CAGR of 0% in the historical period.
  • By deception stack, the network security segment is predicted to witness 2% CAGR from 2023 to 2033.

Engage in a conversation with our research expert to delve deeper into the subject and gain valuable insights for your specific needs

“Across several sectors, compliance rules have tightened, necessitating strong security measures. These needs are met by deception technology, which offers proactive security measures and improves threat detection capabilities. It is further expected to open door to new opportunities in the market.” – Says a lead analyst at Future Market Insights (FMI).

Competitive Landscape

The deception technology market’s competitive environment is dynamic and ever-changing. There are a variety of established businesses, new start-ups, and providers of specialized solutions in the market.

Several well-known businesses have emerged as market leaders in the field of deception technology. These businesses have a significant market presence, a sizable customer base, and a broad portfolio of deception technologies.

They frequently have a history of effective deployments and collaborations with other cybersecurity firms. To remain ahead of new threats and continuously enhance their products, market leaders often make significant investments in research & development.

The deception technology sector is heavily reliant on collaboration and strategic alliances. To increase their reach, businesses frequently form agreements with other cybersecurity vendors, managed security service providers, or system integrators.

They also want to increase the number of clients they serve and provide all-inclusive services. Through the harnessing of synergies and the pooling of capabilities, partnerships can increase market competitiveness.

For instance,

  • The Cybersecurity & Infrastructure Security Agency (CISA), a division of the Department of Homeland Security, announced in April 2022 that its FedRamp Ready ShadowPlex platform had been included. Acalvio Technologies is a pioneer in the field of cyber deception. The business would be able to use and acquire cutting-edge deception technology with the addition of this platform. Additionally, the platform would aid them in thwarting sophisticated foes.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Compression Garments and Stockings Market to Reach USD 4,744.2 Million by 2034, Growing at a CAGR of 4.4%

Global Compression Garments and Stockings Industry
Global Compression Garments and Stockings Market

The global market for compression garments and stockings is poised for significant growth over the next decade, with sales expected to climb from USD 3,084.3 million in 2024 to an estimated USD 4,744.2 million by 2034, reflecting a steady CAGR of 4.4%. According to recent data, the revenue generated in 2023 was USD 2,954.3 million, underscoring the market’s upward trajectory.

The increasing awareness of the health benefits associated with compression therapy, especially for managing circulatory issues and improving athletic performance, is a major factor driving demand. Compression garments and stockings are widely adopted for their role in enhancing blood circulation, reducing swelling, and providing support during physical activities, making them popular among athletes and individuals with chronic venous disorders.

Advances in technology and an increasing interest in venous health, post-surgical recovery, and sporting performance drive the market for compression garments and stockings. The compression garments are widely applied not only to manage venous disorders, lymphedema, and other circulation problems but also as an integral part of the recovery routine for athletes. Even more comfortable, durable, and effective compression products offered through advances in technology have resulted in improved patient compliance and satisfaction.

A new product innovation from players like Sigvaris Group and Medi GmbH is trying to meet the therapeutic and performance-related demands in the market. Growth in this market is also boosted by rising awareness about the benefits of compression therapy in better managing chronic conditions and recovery support. Hence, they are an essential component both in the healthcare and sports sectors.

Competitive Landscape

The market for compression garments and stockings is highly competitive, encompassing a mix of both established players as well as new entrants in the space. Companies within this space are starting to focus more on their product lines with advanced technologies and materials catering to higher medical and athletic needs. Strategic partnerships, mergers, and acquisitions have become somewhat common occurrences as firms seek to expand their market presence and integrate cutting-edge solutions to address the growing demand for effective compression therapy.

Recent Industry Developments in the Compression Garments and Stockings Market

  • 3M Launched advanced compression stockings with moisture-wicking fabrics on March 15, 2024.
  • BSN Medical Introduced a series of antimicrobial compression garments on April 10, 2024.

Key Players of the Compression Garments and Stockings Industry

  • 3M
  • BSN Medical
  • Covidien Ltd.
  • Medi GmBH & Co KG
  • SIGVARIS
  • Therafirm
  • 2XU Pty. Ltd.
  • Santemol Group Medikal
  • Leonisa, Inc.
  • Nouvelle, Inc.
  • Medical Z

A Comprehensive Full Report

Key Segments of the Compression Garments and Stockings Industry

By Product:

In terms of product, the industry is divided into compression garments (upper compression garments and lower compression garments), compression stockings (anti-embolism compression stockings and gradient compression stockings)

By Application:

In terms of application, the industry is divided into varicose veins, wound care, burns, oncology, and others

By Distribution Channel:

In terms of distribution channels, the industry is divided into hospitals, ambulatory surgical centers, clinics, online sales, and other healthcare facilities

By Region:

Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube